Abstract:Chronic inflammation of the urinary tract is a significant risk factor for the development of urinary bladder cancer in man. Previously we have shown that acute and chronic inflammation induced by repeated intravesical instillation of killed Escherichia coli (KEC) strikingly enhanced N-methyl-N-nitrosourea (MNU)-initiated bladder carcinogenesis in our heterotopically transplanted rat urinary bladder model. We conducted the present study to determine whether delayed onset of KEC treatment can still enhance carcinogenesis of the MNU-initiated urothelium and whether continuous KEC treatment is necessary for the development of tumors. After the initiation of carcinogenesis in heterotopically transplanted bladders by the instillation of a single dose (0.25 mg) of MNU, animals were divided into several groups, for which weekly KEC treatment (5 x 10(8) cells suspended in 0.5 ml of phosphate-buffered 2.1% NaCl solution) was begun 1, 5, and 18 weeks later and continued until termination of the experiment at 31 weeks. In addition, animals received 4-week KEC treatment, which was started 1 or 5 weeks after MNU administration. Treatment with KEC alone or MNU alone induced few tumors. Maximal tumor development was demonstrated in the group receiving KEC treatment continuously throughout the experimental period. Delaying the onset of continuous KEC treatment by 4 weeks resulted in a significant decrease in the number of tumors (P = 0.006). However, a substantial number of tumors were induced even when KEC treatment was delayed as many as 18 weeks, as compared to tumor development in the group receiving MNU only (P = 0.007). The tumor volume (size) was not different between continuous and short-term KEC treatment groups. We conclude that (a) although a large number of cells undergo promutagenic DNA damage by a single dose of MNU, the amounts are reduced quickly during the subsequent 4 weeks; but that (b) a substantial number of genetically altered cells remain for a long time and can be promoted to tumors when stimulated by a chronic inflammatory stimulus; and that (c) the duration of KEC treatment determines the number, but not the volume, of tumors.

[Development of a Cryosurgery & Radiofrequency Alternating Tumor Ablation Device].

Numerical Simulation On Heat Transfer In A Novel Combined Therapy Of Nano-Cryosurgery And Rf Hyperthermia

Thermal ablation in cancer

Beyond Liquid Nitrogen Coolant: Extreme Freezing To Maximize Cryosurgical Ablation Of Tumor

CONFORMAL RF ABLATION TO REDUCE "DEAD REGION" WITH ADJUVANT INJECTION OF MAGNETIC MICRO/NANO PARTICLES: FEASIBILITY STUDY

Liquid metal bath as conformable soft electrodes for target tissue ablation in radio-frequency ablation therapy

History, Principles, and Techniques of Radiofrequency Ablation

Anatomical Model-Based Finite Element Analysis of the Combined Cryosurgical and Hyperthermic Ablation for Knee Bone Tumor.

Enhancement of Rf Ablation by Combined Use of Ultra-Low Temperature Fluid Cooling and Magnetic Nanoparticles

Biosynthesis of dicarboxylic acids by carbon dioxide fixation. V. Further study of the "malic" enzyme of Lactobacillus arabinosus.

Minimally Invasive Probe System Capable of Performing Both Cryosurgery and Hyperthermia Treatment on Target Tumor in Deep Tissues.

Experimental Study of a Novel Radiofrequency Ablation System

Research progress on anti-tumor immune effect of cryoablation

LASER ASSISTED CRYOSURGICAL RESECTION OF MALIGNANT TUMOR TISSUES

Development of Experimental System for Tumor Thermochemical Ablation

Performance of Self-Made Cryosurgical and Hyperthermia Equipment for Targeted Tumor Treatment

NUMERICAL SIMULATION OF 3-D FREEZING AND HEATING PROBLEMS FOR COMBINED CRYOSURGERY AND HYPERTHERMIA THERAPY

Progress in the cryoablation and cryoimmunotherapy for tumor

Persistence of carcinogen-altered cell population in rat urothelium which can be promoted to tumors by chronic inflammatory stimulus.

Analyzing the Influence Factors of Brain Tumor Cryoablation